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Genetic and environmental risk factors for
rheumatoid arthritis in a UK African ancestry
population: the GENRA casecontrol study
Matthew Traylor1, Charles Curtis2, Hamel Patel2, Gerome Breen2, Sang Hyuck
Lee2, Xiaohui Xu2, Stephen Newhouse2, Richard Dobson2, Sophia Steer3,
Andrew P. Cope4, Hugh S. Markus5, Cathryn M. Lewis1,2,* and Ian C. Scott1,4,a,b,*
Abstract
Objectives. To evaluate whether genetic and environmental factors associated with RA in European and
Asian ancestry populations are also associated with RA in African ancestry individuals.
Methods. A casecontrol study was undertaken in 197 RA cases and 868 controls of African ancestry
(Black African, Black Caribbean or Black British ethnicity) from South London. Smoking and alcohol
consumption data at RA diagnosis was captured. Genotyping was undertaken (Multi-Ethnic Genotyping
Array) and human leukocyte antigen (HLA) alleles imputed. The following European/Asian RA susceptibility
factors were tested: 99 genome-wide loci combined into a genetic risk score; HLA region [20 haplotypes;
shared epitope (SE)]; smoking; and alcohol consumption. The SE was tested for its association with
radiological erosions. Logistic regression models were used, including ancestry-informative principal com-
ponents, to control for admixture.
Results. European/Asian susceptibility loci were associated with RA in African ancestry individuals. The
genetic risk score provided an odds ratio (OR) for RA of 1.53 (95% CI: 1.31, 1.79; P= 1.3  10 7). HLA
haplotype ORs in European and African ancestry individuals were highly correlated (r= 0.83, 95% CI: 0.56,
0.94; P= 1.1  10 4). Ever-smoking increased (OR = 2.36, 95% CI: 1.46, 3.82; P= 4.6  10 4) and
drinking alcohol reduced (OR = 0.34, 95% CI: 0.20, 0.56; P= 2.7  10 5) RA risk in African ancestry
individuals. The SE was associated with erosions (OR = 2.61, 95% CI: 1.36, 5.01; P= 3.9  10 3).
Conclusion. Geneenvironment RA risk factors identified in European/Asian ancestry populations are
relevant in African ancestry individuals. As modern statistical methods facilitate analysing ancestrally di-
verse populations, future genetic studies should incorporate African ancestry individuals to ensure their
implications for precision medicine are universally applicable.
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Rheumatology key messages
. RA geneenvironment risk factors in European and Asian populations are generalizable to African ancestry
individuals.
. Smoking and alcohol (dominant European/North-American environmental RA risks) are associated with RA in
African ancestry individuals.
. The shared epitope predicts erosive status in African ancestry RA patients.
Introduction
RA is a complex disease resulting from environmental ex-
posures in genetically predisposed individuals [1]. Many
genetic and environmental RA risk factors have been
identified in European and Asian ancestry individuals
[25]. Their generalizability to other ancestral populations
is uncertain. The benefits of establishing RA risk factors
include facilitating the identification of novel therapeutic
targets [5] and risk prediction modelling [6].
Although RA causes significant health-care burdens in
Africa [7], few studies have assessed RA risk factors in
Africa or African ancestry groups. Relevant Africa-based
research comprises several small casecontrol studies
(including<60 cases) [810]. Two Cameroonian studies
showed the shared epitope (SE) was three times com-
moner in RA cases [9], but a genetic risk score (GRS) of
28 European RA risk single nucleotide polymorphisms
(SNPs) was not associated with RA [8]. A Senegalese
study reported increased RA risk in HLA-DR3 and HLA-
DR10 carriers [10]. RA susceptibility factors in African
Americans are better characterized, with smoking and
the SE being established risk factors [11]. To date, no
studies have examined RA risks in UK-based African an-
cestry individuals. As UK, USA and Africa-based African
ancestry populations are ethnically different (using differ-
ent self-reported ethnicity classifications), and are likely to
differ genetically (with varying degrees of genetic admix-
ture), it is crucial to evaluate RA risks in African ancestry
individuals living in the UK.
We evaluated whether geneenvironment RA risk fac-
tors identified in European and Asian ancestry populations
are relevant to African ancestry UK individuals. Our novel
casecontrol study (comprising 197 RA cases and 868
controls of Black African, Black Caribbean and Black
British ethnicity) tested whether: the HLA locus, 99
genome-wide loci, smoking, and alcohol consumption
were associated with RA in this population. We also com-
pared HLA region contributions to RA risk in African and
European ancestry individuals, and evaluated associ-
ations between the SE and radiological erosions.
Methods
Guidelines
The STrengthening the Reporting of OBservational studies
in Epidemiology (STROBE) guidelines have been devised
to strengthen transparency in the analysis and reporting of
observational studies. We adhered to the STROBE check-
list for study reporting [12].
Subjects
African ancestry cohort
African ancestry cases were from the GENetics of RA in
individuals of African ancestry (GENRA) study [13].
GENRA recruited 212 patients (January 2011 to
February 2015) from rheumatology clinics in four South
London hospitals (Guy’s, King’s College, St George’s
and Lewisham). Inclusion criteria comprised an RA diag-
nosis fulfilling the 1987/2010 ACR criteria, and Black
African, Black Caribbean or Black British self-reported
ethnicity [14]. Patients were assessed once, recording
ethnicity, disease characteristics (year diagnosed, medi-
cations, serology, extra-articular features) and outcomes
(disease activity, disability, quality of life). Patients were
asked about current and previous smoking, including
time-points for starting/stopping smoking, cigarettes/day
(or alternatives) and breaks from smoking. Alcohol intake
was assessed by asking if they were current, previous or
never drinkers; alcohol intake (units/day) at diagnosis was
collected. Hand and feet radiographs were evaluated for
erosions; if unavailable, documentation of erosions in the
clinical notes was captured. Serum and DNA was ex-
tracted from whole blood.
African ancestry controls (n= 887) were included from
the South London Ethnicity and Stroke Study (SLESS)
[15]. Inclusion criteria comprised being of Black
Caribbean or Black African ethnicity, and being free of
clinical cerebrovascular disease. SLESS control recruit-
ment was by random selection from primary care lists in
St George’s, Guy’s and St Thomas’, and King’s College
Hospital catchment areas between 1999 and 2012; email-
ing St George’s University of London/St George’s Hospital
staff; and affixing posters publicizing the study in local
leisure centres, primary care surgeries, churches and
communities centres. Using population controls from the
same catchment area as cases reduced selection bias
risk. Lifestyle habits were captured by self-completed
questionnaire, checked and completed, if necessary, by
a clinician interviewing participants. Smoking was as-
sessed by asking: Do you smoke? and Are you an ex-
smoker? Alcohol intake was assessed by asking: How
many alcohol units do you drink per week?
European ancestry cohort
We included European ancestry cases from the
Combination Anti-Rheumatic Drugs in Early RA
(CARDERA) genetics cohort and controls from the
Wellcome Trust Case Control Consortium 2 (WTCCC2)
to compare the contribution of the SE to RA risk between
African and European ancestry groups. Both cohorts have
been described previously [16, 17]. CARDERA comprises
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524 patients with early, active RA enrolled in two clinical
trials. WTCCC2 controls are from the 1958 Birth Cohort.
Genotyping
GENRA and SLESS were genotyped together on the Illumina
Multi-Ethnic Genotyping Array, a multi-ethnic platform
with>1.7 million markers [18]. Quality control (QC) and im-
putation procedures are described in supplementary Table
S1, available at Rheumatology Online. Post-QC 197 cases
and 868 controls were available. Principal components (PCs)
were calculated, combining GENRA/SLESS with individuals
from 1000 Genomes phase 3 populations using smartpca
(EIGENSTRAT) on an LD-pruned subset of data [19]. Data
were imputed to the 1000 Genomes phase 3 reference set
using IMPUTE2 (ver. 2.3.0); 4-digit HLA alleles were imputed
using HLA*IMP:02 (multi-ethnic reference panel, imputing 4-
digit HLA alleles with 84% accuracy in Africans) [20].
CARDERA cases and WTCCC2 controls were geno-
typed separately on the Illumina Immunochip [21]. QC
was initially performed on each dataset separately and
subsequently after merging (using the same procedures
as for GENRA/SLESS). PC analysis (PCA) was performed
using smartpca (EIGENSTRAT) on an LD-pruned subset
[19]. Individuals were removed that were>8 S.D.s from the
mean of the first five PCs. Post-QC 520 cases and 2648
controls were available. Imputation of HLA alleles was
performed with HLA*IMP:02 (European reference panel,
imputing 4-digit HLA alleles with 94% accuracy in
Europeans) [20].
Statistical analysis
HLA associations
Raychaudhuri et al. [22] showed that most HLA-derived
risk for ACPA-positive RA in Europeans is from poly-
morphisms in five amino acids [22].
These define 16 haplotypes in HLA-DRb1, 2 haplotypes
in HLA-B and 2 haplotypes in HLA-DPb1. We tested their
association with RA in our African and European ancestry
cohorts using logistic regression. In GENRA/SLESS, the
first 10 ancestry-informative PCs were included as covari-
ates, to adjust for admixture. Pearson’s correlation coef-
ficient tested correlations between the log [odds ratios
(ORs)] for association of each HLA haplotype in the
meta-analysis, and GENRA/SLESS. As Raychaudhuri et
al. determined these haplotypes by using omnibus tests
to define critical HLA-DRb1 molecule amino acid positions
for RA susceptibility, we additionally used omnibus tests to
evaluate the associations between the critical amino acid
positions 11, 13, 71 and 74 in HLA-DRb1 and RA in our
African and European ancestry cohorts. We also tested
associations between the SE and RA using logistic regres-
sion. Nagelkerke’s [23] measure of proportion of trait vari-
ance explained compared the degree of RA risk explained
by the SE in European and African ancestry individuals.
Genome-wide associations
A trans-ethnic RA genome-wide association study
(GWAS) meta-analysis by Okada et al. [5] identified 102
risk SNPs in European and Asian ancestry individuals. We
constructed a genetic risk score (GRS) including 99 of
these variants [omitting two X-chromosome markers,
and one SNP (rs147622113) not present in Africans] and
tested its association with RA in our African ancestry
cohort using logistic regression, including the first 10 an-
cestry-informative PCs. All SNPs included in the GRS had
INFO scores>0.55. The GRS was created by summing
the number of risk alleles carried at each SNP, weighted
by its log (OR). To ensure the GRS association with RA in
GENRA/SLESS was not due to European admixture, we
divided GENRA cases into quartiles based on PC 1
(separating European and African ancestry individuals)
and repeated the GRS analysis for cases in each quartile
against all controls. It was not possible to test the asso-
ciation between the GRS and RA in our European ances-
try cohort because CARDERA was genotyped on the
ImmunoChip, which is missing a substantial proportion
of the SNPs identified by Okada et al.
Smoking and alcohol associations
Smoking and alcohol abstinence have consistent associ-
ations with RA in European/North American studies [2, 3].
We tested the association between (i) being an ever-
smoker vs never-smoker and drinker vs non-drinker at
RA diagnosis and (ii) casecontrol status in GENRA/
SLESS. GENRA cases were classified as non-drinkers if
they reported being a never drinker or if a current/previous
drinker reported consuming 0 U/week at RA diagnosis.
SLESS controls were classified as non-drinkers if they re-
ported drinking 0 U/week at assessment. Propensity
score matching (1:2 ratio) matched GENRA cases with
SLESS controls for age, sex and ethnicity. As Black
British ethnicity individuals were not recruited to SLESS,
19 Black British GENRA cases were excluded. Eight
GENRA cases and 190 SLESS controls with missing
smoking/alcohol data were also omitted. Associations be-
tween smoking and drinking and RA were tested using
multivariate logistic regression models, including age,
sex and ethnicity as covariates. Due to ethnic differences
in lifestyle habits, a secondary analysis stratifying by eth-
nicity was performed.
SmokingSE interaction
An additive interaction between the SE and smoking on
RA risk is well established in Europeans [24]. We tested
this in GENRA/SLESS using logistic regression models
incorporating smoking (ever vs never-smoking) and the
SE (0 vs any copies), alongside the first 10 ancestry-in-
formative PCs, age and sex as covariates. The interaction
between the SE and smoking was evaluated as the rela-
tive excess risk due to interaction, using the approach
defined by Rothman and Greenland [25].
SE and erosive status
The SE associates with erosions in most RA populations
[26]. We tested this in GENRA cases using logistic regres-
sion including erosions (present vs absent) as the re-
sponse variable, and the first 10 ancestry-informative
PCs, age, sex, ACPA and disease duration as covariates.
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All cases vs ACPA-positive cases
Geneenvironment risk factors for RA have stronger as-
sociations with ACPA-positive disease. We therefore ana-
lysed all RA and ACPA-positive RA cases separately.
Sample size
We had 80% power to detect a common variant [minor
allele frequency (MAF) = 30%] with OR>2.10 at genome-
wide significance (assuming an additive genetic model
and RA prevalence in Africans of 0.75%) [7, 27]. Our
study was therefore powered to replicate European HLA
haplotype associations. Statistical analyses were per-
formed using R, version 3.2.2.
Ethics approval and consent to participate
GENRA (National Research Ethics Service Committee
London—Dulwich, reference: 11/LO/1244), SLESS
(Wandsworth Local Research Ethics Committee, reference:
05/Q0803/324), CARDERA (National Research Ethics Service
Committee East of England—Essex, reference: 11/EE/0544)
and WTCCC2 were ethically approved. All participants pro-
vided consent according to the Declaration of Helsinki. No
additional ethical approval was required for this study.
Results
Study characteristics
African ancestry cohort
Post-QC, there were 197 GENRA cases and 868 SLESS
controls (Table 1). Cases and controls had similar mean
ages (56.3 vs 58.7 years); more cases were female (83%
vs 48%). Most cases had established (mean duration 9.3
years) ACPA-positive (78%) RA. Mean disease activity
was moderate (DAS28 3.97); 40% were erosive.
PCA showed strong segregation of GENRA/SLESS
samples with African populations from 1000 Genomes
phase 3 (Fig. 1). While European admixture in GENRA
and SLESS was observed, this was not significantly dif-
ferent between them. The major PC dividing European
from African ancestry (PC1) was not significantly asso-
ciated with RA status under logistic regression (P= 0.27).
European ancestry cohort
Post-QC, there were 520 CARDERA cases and 2648
WTCCC2 controls. More cases were female (68% vs
48%). Cases had early, active disease at trial baseline
(mean duration 0.28 years; mean DAS28 5.88). Most
were ACPA-positive (70%).
HLA imputation
HLA alleles were imputed with a high-degree of certainty
(supplementary Figs S14, available at Rheumatology
Online). In GENRA/SLESS, 232 alleles were imputed at
4-digit resolution; 127 alleles had a frequency of>1%.
The median posterior probability (Q) of allele allocation
was 0.974; 88.1% of alleles were imputed with Q> 0.9;
96.3% were imputed with Q> 0.8. In CARDERA/
WTCCC2, 183 alleles were imputed at 4-digit resolution;
111 of these had a frequency of >1%. The median Q of
allele allocation was 0.975; 87.3% of alleles were imputed
with Q> 0.9; 96.8% were imputed with Q> 0.8. Lower
frequency alleles were imputed with less certainty, as ex-
pected due to their rarity in reference panels. Imputation
posterior probabilities for the HLA region were in general
similar between RA cases and controls, with no significant
differences between them as assessed by linear regres-
sion. The exception was for HLA-DPB1, which showed
slightly lower imputation quality in controls compared
with cases (P= 0.024).
TABLE 1 African and European ancestry cohort characteristics
African Ancestry European Ancestry
Characteristic
GENRA cases
(n = 197)
SLESS controls
(n = 868)
CARDERA cases
(n = 520)
WTCCC2 controls
(n = 2648)
Demographics
Female, n (%) 164 (83.3) 416 (47.9) 355 (68.4) 1278 (48.3)
Age, years 56.3 (14.9) 58.7 (12.0) 54.6 (12.6) 
RA characteristics
Disease duration, years 9.3 (10.2)  0.28 (0.41) 
ACPA-positive, n (%) 153 (77.7)  347 (70.1) 
RF-positive, n (%) 152 (77.2)  349 (67.1) 
DAS28 3.97 (1.59)  5.88 (1.28) 
Erosions, n (%) 79 (40.1)   
Shared epitope
0 SE copies, n (%) 112 (56.9) 666 (76.8) 135 (25.9) 1302 (49.2)
1 SE copy, n (%) 76 (38.6) 192 (22.1) 273 (52.5) 1137 (42.9)
2 SE copies, n (%) 9 (4.6) 9 (1.0) 112 (21.5) 209 (7.9)
Data are mean (S.D.) unless otherwise stated. ACPA status missing in 25 CARDERA cases; smoking data missing in 1 GENRA
case and 0 SLESS controls; alcohol consumption data missing in 11 GENRA cases and 190 SLESS controls. SE: shared
epitope.
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HLA associations with RA in African and European
ancestry cohorts
HLA haplotypes had similar effects on RA risk in GENRA/
SLESS to those observed in the European meta-analysis
(Table 2). Using the commonest control haplotype in the
meta-analysis as the reference haplotype, in GENRA/
SLESS only 2 (from 15 available non-reference haplo-
types) had ORs in opposing directions to the European
meta-analysis. In CARDERA/WTCCC2, 4 (from 16 avail-
able non-reference haplotypes) had ORs in opposing dir-
ections to the European meta-analysis. Haplotype ORs in
GENRA/SLESS and the European meta-analysis were
highly correlated (r= 0.83, 95% CI: 0.56, 0.94; P= 1.1 
10 4; Fig. 2). In GENRA/SLESS one further haplotype
was observed, which was not present in Europeans
[encoded by HLA-DRB1*14:04; MAF = 0.005; OR = 0.96].
Omnibus tests showed highly significant associations
for amino acid positions 11 and 13 in HLA-DRb1 (P= 8.1
 10 9, P= 7.8  10 9, respectively) and casecontrol
status in GENRA/SLESS, but not positions 74 (P= 0.017)
and 71 (P= 0.20). In CARDERA/WTCCC2, highly signifi-
cant associations were observed for amino acids pos-
itions 11, 13 and 71 in HLA-DRb1 (P= 1.6  10 10,
P= 1.2  10 10 and P= 5.0  10 9, respectively) with
casecontrol status. The association at position 74 was
not significant (P= 0.058).
SE alleles were rarer in African than European ancestry
individuals (Tables 1 and 3). The data indicated a SE fre-
quency of 24% and 12% in GENRA cases and SLESS
controls, respectively, and 48% and 29% in CARDERA
cases and WTCCC2 controls, respectively. The OR for
RA per SE copy was similar in African (OR = 2.41, 95%
CI: 1.80, 3.23; P= 4.6  10 9) and European (OR = 2.27,
95% CI: 2.05, 2.51; P= 1.6  10 57) ancestry cohorts.
The proportion of variance in casecontrol status ex-
plained by the SE was also similar (African R2=0.050;
European R2=0.069). The SE was commoner in ACPA-
positive cases, with larger effects on risk observed
(Table 3).
Genome-wide SNP associations with RA in African
ancestry individuals
The GRS was significantly associated with RA in GENRA/
SLESS (OR = 1.53, 95% CI: 1.31, 1.79; P= 1.3  10 7).
Although the HLA SNP included in the GRS contributed a
substantial part of this signal, a significant association re-
mained when it was omitted (OR = 1.30, 95% CI: 1.11,
1.52; P= 0.0011). The association was stronger when re-
stricting to ACPA-positive cases (OR = 1.75, 95% CI:
1.47, 2.08; P= 5.0  10 10); this remained significant on
omitting the HLA SNP (OR = 1.40, 95% CI: 1.18, 1.67;
P= 1.7  10 4). Individual SNP associations are provided
in supplementary Table S2, available at Rheumatology
Online.
Dividing GENRA cases into quartiles based on their pro-
portion of European ancestry (captured by the first PC)
and repeating the GRS analysis for each quartile against
all controls ensured the association was not driven by
European admixture (supplementary Fig. S5, available at
Rheumatology Online).
Plotting the ORs for RA associated with each SNP in the
Okada et al. meta-analysis and our GENRA/SLESS
African ancestry cohort and scaling each point by their
minor allele frequency (supplementary Fig. S6, available
at Rheumatology Online) showed that the majority of
common RA susceptibility SNPs share a direction of
FIG. 1 First two ancestry-informative principal components in GENRA, SLESS, and 1000 genomes phase 3 samples
(A) GENRA, SLESS and 1000 genomes phase 3 samples. (B) GENRA and SLESS samples only; (B) is an enlarged
representation of the results presented in (A), without including the 1000 genomes phase 3 samples. AFR: African; AMR:
Admixed American; EAS: East Asian; EUR: European; SAS: South Asian.
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effect in the meta-analysis and our African ancestry
cohort. Although there are some SNPs that have an op-
posite direction of effect, these are generally rare. Overall
56/99 (57%) of SNPs share a direction of effect between
the Okada et al. meta-analysis and our African ancestry
cohort. Stratifying this analysis by MAF shows that for
markers with MAF> 0.01, 52/90 (58%) share a direction
of effect; for markers with MAF> 0.05, 49/78 (63%) share
a direction of effect; and for markers with MAF> 0.1, 44/
64 (69%) share a direction of effect.
Association between smoking, alcohol and RA in African
ancestry individuals
Smoking was associated with RA in GENRA/SLESS
(Table 4). The OR for RA in ever vs never-smokers was
2.36 (95% CI: 1.46, 3.82; P= 4.6  10 4). Similar results
were observed for ACPA-positive cases (OR = 2.13, 95%
CI: 1.24, 3.66; P= 6.0  10 3; supplementary Table S3,
available at Rheumatology Online). Univariate estimates
remained significant (supplementary Table S4, available
at Rheumatology Online). There was no evidence of an
interaction between the SE and smoking on RA risk,
FIG. 2 RA Odds ratios for HLA haplotypes in the African/European studies vs the European meta-analysis
(A) All African ancestry RA cases. (B) ACPA-positive African ancestry RA cases. (C) All European ancestry RA cases.
(D) ACPA-positive European ancestry RA cases. All European ancestry cases in meta-analysis were ACPA-positive;
reference haplotypes [i.e. those with log (OR) = 0] not plotted. African study: GENRA/SLESS; European study: CARDERA/
WTCCC2; European meta-analysis is the study by Raychaudhuri et al.
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when evaluated on the additive scale (OR = 3.15, 95% CI:
0.25, 39.9).
Alcohol consumption had a significant inverse relation-
ship with RA in GENRA/SLESS. The OR for RA in drinkers
vs non-drinkers was 0.34 (95% CI: 0.20, 0.56; P= 2.7 
10 5). The association was marginally stronger for
ACPA-positive RA (OR = 0.30, 95% CI: 0.17, 0.53;
P= 3.9  10 5; supplementary Table 3, available at
Rheumatology Online). While smoking and drinking rates
were lower in Black African individuals compared with
Black Caribbean individuals, ORs for RA associated with
smoking and alcohol were similar in these ethnic groups
(Table 4).
SE and erosive status in African ancestry cases
The SE was significantly associated with erosions in
GENRA. The OR for RA per SE copy was 2.61 (95% CI:
1.36, 5.01; P= 3.9  10 3) in all RA cases, and 3.35 (95%
CI: 1.64, 6.91; P= 1.0  10 3) in ACPA-positive cases.
Discussion
We studied whether geneenvironment RA risk factors
identified in European and Asian ancestry populations
are relevant in UK-based African ancestry individuals.
Our study has three key findings. First, we showed that
EuropeanAsian RA susceptibility loci (a 99 SNP GRS and
20 HLA haplotypes) are associated with RA in African an-
cestry individuals. Second, we found that smoking and
alcohol (dominant European/North American environmen-
tal RA risks [2, 3]) are associated with RA in African an-
cestry individuals. Third, we demonstrated that the SE,
which predicts radiological damage in a range of ancestral
groups [26] also predicts erosive status in African ancestry
RA patients. Overall, our findings provide strong evidence
for a shared geneticenvironmental architecture for RA
across European, Asian and African ancestry populations.
We used three approaches to examine the association
between the HLA locus and RA in GENRA/SLESS. First, we
used the 20 haplotype model proposed by Raychaudhuri et
al. [22]; second, we used omnibus tests to evaluate the
critical amino acid positions in HLA-DRb1 identified by
Raychaudhuri et al.; and third, we used the SE. In all
three instances, the HLA region had a highly significant
association with RA. While amino acid position 71 was
not associated with RA in GENRA/SLESS, the relevance
of this is uncertain, as the SE (which spans positions
7174) had a highly significant association with RA status.
TABLE 4 Association between smoking, alcohol and RA in African ancestry cases and controls
Characteristic GENRA cases SLESS controls OR (95% CI) P-value
Black Caribbean and Black African individuals (GENRA, n = 170; SLESS, n = 340)
Age, mean (S.D.), years 57.2 (14.9) 58.9 (11.8) 0.99 (0.97, 1.00) 0.11
Female, n (%) 141 (82.9) 282 (82.9) 1.09 (0.61, 1.94) 0.77
Caribbean ethnicity, n (%) 104 (61.1) 217 (63.8) 0.88 (0.58, 1.34) 0.56
Ever-smoker, n (%) 54 (31.8) 59 (20.3) 2.36 (1.46, 3.82) 4.6  104
Alcohol drinker, n (%) 28 (16.5) 108 (31.8) 0.34 (0.20, 0.56) 2.7  105
Black Caribbean individuals (GENRA, n = 104; SLESS, n = 217)
Ever-smoker, n (%) 44 (42.3) 55 (25.3) 2.54 (1.46, 4.43) 9.7  104
Alcohol drinker, n (%) 20 (19.2) 76 (35.0) 0.33 (0.18, 0.61) 4.4  104
Black African individuals (GENRA, n = 66; SLESS, n = 123)
Ever-smoker, n (%) 10 (15.2) 14 (11.4) 2.86 (0.96, 8.52) 0.059
Alcohol drinker, n (%) 8 (12.1) 32 (26.0) 0.35 (0.14, 0.87) 0.025
Cases and controls matched for age, sex and ethnicity. ORs for RA associated with smoking are adjusted for age, gender and
drinking status (and ethnicity in analysis of all individuals); ORs for RA associated with drinking are adjusted for age, gender
and smoking status (and ethnicity in analysis of all individuals); unadjusted ORs are given in supplementary Table S4, available
at Rheumatology Online.
TABLE 3 Shared epitope impact on RA risk in African and
European ancestry cohorts
SE freq and
association
with RA European cohort African cohort
All RA
SE freq (cases) 0.48 0.24
SE freq (controls) 0.29 0.12
OR (95% CI) 2.27 (2.05, 2.51) 2.41 (1.80, 3.23)
P-value 1.6  1057 4.6  109
R2 0.069 0.050
ACPA + RA
SE freq (cases) 0.54 0.28
SE freq (controls) 0.29 0.12
OR (95% CI) 3.03 (2.68, 3.42) 3.03 (2.20, 4.20)
P-value 2.9  1071 7.9  1012
R2 0.107 0.079
R2 : Nagelkerke’s measure of proportion of trait variance ex-
plained. Freq: SE allele frequency; OR: odds ratio per copy
of SE allele carried in additive model (relative to no SE
copies).
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Although SE alleles were rarer in Africans than Europeans,
the difference in the proportion of SE allele carriers between
cases and controls was similar in both GENRA/SLESS and
CARDERA/WTCCC2, resulting in similar ORs for RA.
Additionally, the proportion of variance in casecontrol
status explained by the SE was similar, albeit slightly
lower in GENRA/SLESS (R2=0.050) compared with
CARDERA/WTCCC2 (R2=0.069). This suggests that the
HLA region has a comparable impact on RA susceptibility
in European and African ancestry groups.
Our study lacked the power to detect individual SNP as-
sociations with RA in GENRA/SLESS. We therefore tested a
GRS combining validated RA susceptibility SNPs. This ap-
proach is widely used to replicate genetic risks in polygenic
disorders, whose genetic architecture comprises hundreds
to thousands of very small effect common alleles [28, 29].
Excluding the HLA-tagging SNP from our GRS reduced the
significance of the association, suggesting that as in
Europeans, most of RA’s heritability is from the HLA
locus. It is improbable that all validated susceptibility
SNPs reported by Okada et al. would replicate in a similarly
sized African ancestry cohort, but our analysis supports the
concept of an overall shared burden of genetic RA risk loci
across ancestral groups.
Smoking and abstinence from alcohol increased RA risk
in African ancestry individuals, replicating the effects
observed in Europeans. While we observed larger ORs
for RA associated with these factors compared with the
pooled study risks observed in published meta-
analyses—meta-analysis OR for RA in drinkers vs non-
drinkers of 0.78 (95% CI: 0.63, 0.96) [2] and ever- vs
never smokers of 1.40 (95% CI: 1.25, 1.58) [3]—our
modest sample size limited our precision in estimating
risk. The ethnic differences we observed in alcohol and
smoking habits—with smoking and drinking being com-
moner in Black Caribbean, compared with Black African
individuals—highlight the importance of considering eth-
nicity when evaluating lifestyle factors, although the small
sample sizes of these ethnic subgroups means this finding
requires interpreting with caution.
This is the first analysis of associations between
erosions and the SE in UK-based African ancestry individ-
uals. The OR of 2.60 in GENRA was similar to a meta-
analysis of eight studies containing 532 Northern
European RA patients, reporting an OR for RA with one
SE allele of 2.4 [26]. In GENRA the association appeared
independent of ACPA, which was included as a modelling
covariate. More recently we, along with other research
groups, have demonstrated a significant association be-
tween the presence of Valine at position 11 (external to the
SE) in HLA-DRb1 and radiological damage in European
ancestry RA patients [17, 30]. Testing this position in
GENRA also revealed a significant association with ero-
sions (OR = 2.15, 95% CI: 1.02, 4.53; P= 0.047), although
we could not confirm this was independent of the SE
owing to our limited sample size.
Our study has several strengths. First, it is the first ana-
lysis of RA risk factors in Black British and Black
Caribbean individuals. Second, we evaluated a broad
range of geneticenvironmental factors. Third, pooling
African ancestry ethnic groups and using computational
techniques to account for population stratification opti-
mized study power. Fourth, population controls were
used from the same catchment area as cases. It also
has limitations. First, the absence of HLA allele genotyping
prevented imputation internal validation; however, poster-
ior-probability scores suggested common HLA variants
were accurately imputed: HLA*IMP:02 has documented
accuracy at imputing HLA alleles [20], and the SE preva-
lence in GENRA (24%) was similar to that observed in
Cameroonian RA cases (30%) [9]. Second, as RA patients
retrospectively recalled lifestyle habits at diagnosis, recall
bias was possible. In the context of alcohol, this could
inflate the effect seen (RA patients often abstain from al-
cohol with DMARD use, which could make them more
likely to classify themselves as non-drinkers at diagnosis).
Third, different methods were used to evaluate lifestyle
habits in cases and controls. Finally, controls were not
screened for RA; however, its low prevalence (0.60.9%
in Africans [7]) suggests few would have this disease, and
it is not routine practice to screen controls for disease in
genetic studies of low prevalence disorders.
Despite increasing UK ethnic diversity (2631% of our
local South London community are of Black ethnicity [31,
32]), few ethnic minority patients participate in research.
This issue is particularly pressing in genetic studies, as
GWAS traditionally exclude non-Europeans to minimize
population stratification. This calls into question the gen-
eralizability of research findings to ethnic minority groups.
As statistical advances facilitate genomic analyses of an-
cestrally diverse populations [33, 34], we undertook a
proof-of-concept GWAS (including the first 10 ancestry-
informative PCs) in our ancestrally heterogeneous
GENRA/SLESS cohort (supplementary Figs S7 and S8,
available at Rheumatology Online). The genomic-inflation
factor was 0.99, suggesting appropriate control for popu-
lation stratification. We therefore propose that future
GWAS meta-analyses include African ancestry samples.
In conclusion, genetic and environmental factors for RA
susceptibility and severity in European and Asian ancestry
populations are generalizable to African ancestry individ-
uals. Greater efforts are needed to include ethnic minorities
in research. This will ensure research findings and their po-
tential for clinical benefit (which in the context of suscept-
ibility loci and prognostic markers includes prevention and
precision medicine) are universally translatable.
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